Jordi Hernández Ribera

Title: The Innovative Contributions of Jordi Hernández Ribera

Introduction

Jordi Hernández Ribera is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of antisense oligonucleotides. His work focuses on innovative solutions for regulating gene expression, which has important implications for medical treatments.

Latest Patents

Hernández Ribera holds a patent for "Antisense oligonucleotides and uses thereof." This patent discloses novel compounds that regulate the splicing of NUMB. Specifically, it provides an antisense oligonucleotide designed to reduce the inclusion of NUMB exon 9 in mature NUMB transcripts. The oligonucleotide comprises a sequence of at least 7 nucleotides that is complementary to a target region within exon 9 of a NUMB transcript. The patent also describes pharmaceutical compositions that include the antisense oligonucleotide and methods for treating proliferative diseases using these compounds.

Career Highlights

Throughout his career, Hernández Ribera has worked with esteemed organizations such as the Institució Catalana de Recerca i Estudis Avançats and the Fundació Centre de Regulació Genòmica. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Juan Alberto Valcárcel Juárez and Elias Bechara. Their collaborative efforts have further advanced the research and applications of antisense oligonucleotides in therapeutic contexts.

Conclusion

Jordi Hernández Ribera's innovative work in the field of biotechnology, particularly through his patent on antisense oligonucleotides, showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various diseases significantly.